	Resveratrol's hepatic symphony: conducting a multi-stage intervention in liver cancer's progression. Chin J Nat Med Guo C, Cao F, Zhou L, Guo G, Zheng S, Xia R, Zou Q. PMID: 42215151 [PubMed - indexed for MEDLINE]
	Durable Survival Outcomes After Liver Transplantation for Colorectal Liver Metastases: A Systematic Review and Single-arm Meta-analysis of Prospective Clinical Trials. J Gastrointest Cancer Saqib HW, Siddiq N, Moazzam M, Hamza M, Ahmad M, Omer M, Khan T, Iqbal MF, Murad A, Khan RA, Bhatti ABH. PMID: 42213206 [PubMed - indexed for MEDLINE]
	Burnt-Out MASLD Predicts Outcomes After Curative Resection for Hepatocellular Carcinoma. Liver Int Watanabe Y, Aikawa M, Murase Y, Oba T, Kageyama Y, Takase K, Watanabe Y, Ono H, Okada K, Okamoto K, Koyama I. PMID: 42212428 [PubMed - indexed for MEDLINE]
	Targeting lactylation in hepatocellular carcinoma: Mechanistic insights and therapeutic opportunities (Review). Int J Mol Med Chen L, Gao F, Mei Q, Li Y, Cai Q, Feng X. PMID: 42212387 [PubMed - indexed for MEDLINE]
	Machine learning-based prediction of hepatocellular carcinoma risk in steatotic liver disease: A nationwide cohort study. PLoS One Kim LY, Lee JS, Yoo JJ, Cho EJ, Kim SG, Kim YS. PMID: 42207764 [PubMed - indexed for MEDLINE]
	Frequency and associated factors of hepatic hemangioma in systemic lupus erythematosus patients undergoing abdominal imaging: a retrospective cohort study. Rheumatol Int Üsküdar Cansu D, Uludo, Y, Önal Birtane G, Y, Özbayrak U, Korkmaz C. PMID: 42207195 [PubMed - indexed for MEDLINE]
	Sintilimab plus fruquintinib with or without radiotherapy for third-line treatment of colorectal cancer with liver metastases: study protocol for a randomized controlled, multicenter phase II trial. Front Immunol Ma Z, Zhu K, Shi F, Feng R, Jiang S, Dou X, Liu J, Niu Z, Yue J. PMID: 42206059 [PubMed - indexed for MEDLINE]
	Comprehensive analysis based on tertiary lymphoid structures and tumor budding predicts survival rates in colorectal cancer patients with synchronous liver metastases. Front Immunol Zhang J, Zhu H, Qian L, Liang M, Miao J, Zhu H, Shen X, Mao Y, Li Q. PMID: 42206052 [PubMed - indexed for MEDLINE]
	Strategies for enhancing delivery efficiency on MR-Linac: A dosimetric study and historical plan review. J Appl Clin Med Phys Zhang Y, Tang S, Kabat C, Visak J, Chiu T, Li R, Jiang S, Lin MH. PMID: 42204767 [PubMed - indexed for MEDLINE]
	Living Donor Liver Transplantation for Colorectal Cancer Liver Metastasis. Gastroenterol Clin North Am Spaggiari M, Kortan E, Alaniz MJ. PMID: 42203398 [PubMed - indexed for MEDLINE]
	Clustering of quantitative CT features identifies HCC subtypes with distinct prognosis and immune signatures. Eur Radiol Exp Wu S, Peng F, Huang J, Xu L, Zhang X, Bao Y, Chen Y. PMID: 42201507 [PubMed - indexed for MEDLINE]
	Risk Factors for Hepatocellular Carcinoma in Latino Populations in Texas: A Scoping Review. Int J Mol Sci Tuzino Kamia LY, Gonzalez E, Swanson CM, Gomez SL, Canales AM, Price RS. PMID: 42196623 [PubMed - indexed for MEDLINE]
	Regulatory T Cells in Hepatocellular Carcinoma: Spatial Niches, Biomarkers, and Clinical Implications. Int J Mol Sci Liapopoulos D, Sarantis P, Zogas G, Trifylli EM, Bousou TE, Kamitaki K, Anastasiou IA, Kokkali S, Mavromatis S, Koustas E, Elefsiniotis I, Biniari T, Karamouzis MV. PMID: 42196608 [PubMed - indexed for MEDLINE]
	CRISPR Screening in Hepatocellular Carcinoma: From Tumor Progression to Immune Evasion and Therapeutic Resistance. Int J Mol Sci Ma S, Li Y, Fei T. PMID: 42196223 [PubMed - indexed for MEDLINE]
	Comparison of Sevoflurane and Desflurane on Hepatocellular Carcinoma Recurrence After Living Donor Liver Transplantation: A Propensity Score-Matched Analysis. Medicina (Kaunas) Bae HJ, Kang SJ, Kim KS, Kwon HM, Jun IG, Song JG, Hwang GS. PMID: 42195128 [PubMed - indexed for MEDLINE]
	Early Recurrence of HCC Is Driven by Inflammation-Related HIF-1Î± Independent Angiogenesis Rather than Hypoxia-Induced Immune Escape. Biomolecules Siregar L, Gani RA, Lalisang TJM, Hasan I, Suhendro, Soejono H, Kresno SB, Siregar NC, Bestari MB. PMID: 42194070 [PubMed - indexed for MEDLINE]
	Deciphering Lipid Metabolic Landscape of Sorafenib-Treated Hepatocellular Carcinoma by Mass Spectrometry Imaging and Transcriptomics. Biomolecules Li D, Tuo Y, Sai L, Xu X, Peng F, Yan Z, Yang Q, Zhao H, Zhang R. PMID: 42194025 [PubMed - indexed for MEDLINE]
	Lenvatinib Combined with New FP Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma: Clinical Efficacy, Vascular Remodeling, and Implications for Immuno-Oncology-Systemic Combination Therapy. Curr Oncol Maruta S, Koshima Y, Debari Y, Sugihara C, Takahata G, Tamura R, Ohshima T, Ono Y, Morita Y, Chiba T, Ishida S, Imai H, Watanabe K, Chinzei R, Takahashi M, Ooka Y. PMID: 42187603 [PubMed - indexed for MEDLINE]
	Imaging Features and Clinical Outcomes of Ischemic Cholangiopathy After Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma: A Retrospective Single-Center Cohort Study and Literature Review. Curr Oncol , Popovi, De, Ur, Zaplotnik M, , Finderle S, . PMID: 42187571 [PubMed - indexed for MEDLINE]
	MRI-based clinicoradiologic model for identifying MT-HCC with distinct postoperative prognosis and potential association with postoperative TKI-ICI therapy. Front Immunol Li Y, Qin Z, Cheng J, Li X, Liu C, Li Q, Zhang H, Cai P, Chen F, Chen W, Li X. PMID: 42183283 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 76245

Page 1 of 3813



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy